| JYSB2000599 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Approval Completed-Pending Certificated | 2021-08-20 | view |
| JXSS2000030 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-07-24 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2021-07-15 | view |
| JXSS2000029 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-07-24 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2021-07-15 | view |
| JXSB2000050 | Durvalumab | durvalumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-21 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2021-05-09 | view |
| JYSB2000600 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2021-03-15 | view |
| JXSB2100011 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-02-06 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2021-02-05 | view |
| JYSB2100016 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-01-12 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Filed | 2021-01-22 | view |
| JYSB2100015 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-01-12 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Filed | 2021-01-22 | view |
| JXSB2100004 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-01-08 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2021-01-07 | view |
| JXSB2000041 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2020-12-03 | view |
| JXSB2000022 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-09-29 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2020-09-28 | view |
| JXSB2000012 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-09-10 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2020-09-09 | view |
| JXSB2000009 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2020-08-19 | view |
| JYSB2000359 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-08-04 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Filed | 2020-08-17 | view |
| JYSB2000358 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-08-04 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Filed | 2020-08-17 | view |
| JXSL2000134 | Durvalumab | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-07-23 | | Medimmune LLC | In Review | 2020-07-22 | view |
| JYSB2000146 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-05-01 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2020-07-16 | view |
| JYSB2000145 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-05-01 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2020-07-16 | view |
| JYSB2000221 | MEDI4736 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | 丘以思（上海）医药信息咨询有限公司 | Choice Pharma Medical Information Consultancy (Shanghai) Co Ltd;Medimmune LLC;MedImmune Pharma BV | In Review | 2020-06-12 | view |
| JXSL2000047 | Durvalumab | durvalumab | Injection | Biological Products | Import Drug Application | 2020-05-18 | | Medimmune LLC | In Review | 2020-05-16 | view |
